Siena Capital’s GSK GSK Stock Holding History

Siena Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.28M	Buy	43,386 +2,952	+7%	+$112K	0.83%	36
2022 Q2	$2.2M	Buy	40,434 +539	+1%	+$29.8K	1.33%	28
2022 Q1	$2.17M	Buy	39,895 +2,356	+6%	+$128K	1.23%	30
2021 Q4	$2.07M	Buy	+37,539	New	+$1.95M	1.19%	29

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Siena Capital's GSK Position: Q3 2022 in Review

Siena Capital increased its GSK (GSK) stake by 7.3% in Q3 2022, buying an estimated $112K and bringing the position to 43,386 shares worth $1.28M. The position accounts for 0.83% of the portfolio, ranked #36.

Siena Capital first reported a position in GSK in Q4 2021 and has held it in 4 quarters since. The position peaked at $2.2M in Q2 2022. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

Siena Capital held 43,386 shares of GSK worth $1.28M as of Q3 2022.
Siena Capital bought 2,952 GSK shares in Q3 2022, an estimated $112K.
GSK made up 0.83% of Siena Capital's portfolio in Q3 2022, its #36 holding.
Siena Capital first reported a position in GSK in Q4 2021 and has held it in 4 quarters since.
Siena Capital's GSK position peaked at $2.2M in Q2 2022.
742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Siena Capital's 13F filing for Q3 2022, filed 2 Nov 2022.